Description | The product is created to satisfy the demand for small volume dosing of concentrated clodronate liposomes through routes that are not amendable for large volume injection, such as intratracheal or intranasal, ICV, or intra-tumor injection. Please note this product has not been fully evaluated for any dosing approaches. Customers are strongly recommended to conduct their own studies to determine the appropriate dose regimen for their experiments. |
Lipid composition | PC/Cholesterol |
Encapsulated Drug | Clodronate disodium (CAS: 22560-50-5) |
Drug concentration | 20 mg/mL |
Buffer | Phosphate buffered saline (20mM sodium phosphate, 09wt% NaCl), pH 7.0-7.5 |
Storage | 2-8 °C |
Shelf-life | 6 months guaranteed for unopened vials. |
Product Name | Catalog | Lipid composition | Liposome Size | Price |
---|---|---|---|---|
Clipos™ Clodronate Encapsulated Liposomes | CDECLD-1686 | L-α-PC/Cholesterol (70/30 molar ratio) | 100 nm | INQUIRY |
Clipos™ Control of Clodronate Encapsulated Liposomes | CDECLD-1690 | L-α-PC/Cholesterol (70/30 molar ratio) | 100 nm | INQUIRY |
Clipos™ Control of Neutral Clodronate Encapsulated Liposome, Lyophilized | CDL7001-NL | PC/Cholesterol | INQUIRY | |
Clipos™ Control of Neutral Clodronate Encapsulated Liposomes | CDL7001-N | PC/Cholesterol | INQUIRY | |
Clipos™ Neutral Clodronate Encapsulated liposomes, Lyophilized | CDL7001C-NL | PC/Cholesterol | INQUIRY | |
Clipos™ Control of Neutral Clodronate Encapsulated Liposomes, High Potency | CDL7001-NH | PC/Cholesterol | INQUIRY | |
Clipos™ Clodronate Encapsulated Liposomes | CDL7001C-N | PC/Cholesterol | INQUIRY | |
Clipos™ Anionic Clodronate Encapsulated Liposomes | CDL7001C-A | PC/PG/Cholesterol | INQUIRY |